CELUW
Celularity Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+533.33%Latest reported
- Last report date
- Nov 14, 2025
- EPS actual
- -$0.88
- EPS estimate
- -$1.50
- Revenue actual
- $5.3M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +41.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026